Skip to main content
Log in

Gefitinib

Acquired resistance and adenocarcinoma transformation to small cell lung cancer: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hwang KE, et al. Transformation to small cell lung cancer as an acquired resistance mechanism in EGFR-mutant lung adenocarcinoma: a case report of complete response to etoposide and cisplatin. Tumori 101: e96-8, No. 3, May 2015. Available from: URL: http://doi.org/10.5301/tj.5000276 - South Korea

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gefitinib. Reactions Weekly 1574, 124 (2015). https://doi.org/10.1007/s40278-015-1580-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-1580-z

Navigation